Adicet Bio receives Nasdaq delisting notice for bid price below $1; cure period to Oct 6, 2025

Adicet Bio, Inc.

Received Nasdaq notice on April 7, 2025 for non-compliance with minimum bid price rule (closing bid <$1 for 30 consecutive days).
Initial compliance period ends October 6, 2025; must close at or above $1 for at least 10 consecutive days to regain compliance.
If not cured, may seek additional 180-day period by transferring to Nasdaq Capital Market and meeting other listing standards.
Company considering reverse stock split as a potential cure; no assurance of regaining compliance or maintaining listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.